[XBP-1 interacts with estrogen receptor alpha (ERalpha)]

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Signaling

Background:

• Estrogen receptor alpha (ERalpha) is a key target and prognostic marker in breast cancer.
• Human X-box binding protein 1 (XBP-1) mRNA levels correlate with ERalpha in tumors and can be overexpressed.
• Previous findings suggest a potential interaction between XBP-1 and ERalpha.

Purpose of the Study:

• To investigate the interaction between XBP-1 isoforms (XBP-1S and XBP-1U) and ERalpha.
• To determine the nature and binding domains of the XBP-1/ERalpha interaction.

Main Methods:

• GST pull-down assays were used to assess in vitro binding of XBP-1 isoforms to ERalpha.
• Co-immunoprecipitation experiments were performed to confirm binding in a cellular context.
• Mapping of interaction regions on both XBP-1 and ERalpha was conducted.

Main Results:

• Both XBP-1S and XBP-1U bound to ERalpha in vitro, with XBP-1S showing stronger binding.
• The interaction between XBP-1 and ERalpha was ligand-independent.
• XBP-1 isoforms interacted with the DNA-binding domain of ERalpha, specifically with XBP-1's bZIP and C-terminal activation domains.

Conclusions:

• XBP-1 isoforms physically interact with ERalpha.
• The interaction occurs in a ligand-independent manner and involves specific domains on both proteins.
• XBP-1 may modulate ERalpha signaling pathways in breast cancer.